BR9701455A - Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado - Google Patents

Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado

Info

Publication number
BR9701455A
BR9701455A BR9701455A BR9701455A BR9701455A BR 9701455 A BR9701455 A BR 9701455A BR 9701455 A BR9701455 A BR 9701455A BR 9701455 A BR9701455 A BR 9701455A BR 9701455 A BR9701455 A BR 9701455A
Authority
BR
Brazil
Prior art keywords
liver diseases
drugs
preparation
treatment
bradykinin antagonists
Prior art date
Application number
BR9701455A
Other languages
English (en)
Inventor
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Klaus Wirth
Max Hropot
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9701455A publication Critical patent/BR9701455A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9701455A 1996-03-27 1997-03-24 Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado BR9701455A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19612067A DE19612067A1 (de) 1996-03-27 1996-03-27 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Publications (1)

Publication Number Publication Date
BR9701455A true BR9701455A (pt) 1998-08-18

Family

ID=7789557

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9701455A BR9701455A (pt) 1996-03-27 1997-03-24 Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado

Country Status (24)

Country Link
US (1) US5863901A (pt)
EP (1) EP0797997B1 (pt)
JP (1) JP4185169B2 (pt)
KR (1) KR100453394B1 (pt)
CN (1) CN1164421A (pt)
AT (1) ATE297749T1 (pt)
AU (1) AU1651697A (pt)
BR (1) BR9701455A (pt)
CA (1) CA2200040A1 (pt)
CZ (1) CZ90797A3 (pt)
DE (2) DE19612067A1 (pt)
DK (1) DK0797997T3 (pt)
ES (1) ES2242973T3 (pt)
HR (1) HRP970171A2 (pt)
HU (1) HUP9700642A3 (pt)
ID (1) ID16413A (pt)
IL (1) IL120521A0 (pt)
NO (1) NO971453L (pt)
PL (1) PL319193A1 (pt)
PT (1) PT797997E (pt)
SI (1) SI0797997T1 (pt)
SK (1) SK39297A3 (pt)
TR (1) TR199700228A2 (pt)
ZA (1) ZA972599B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
AU2009259839A1 (en) * 2008-06-20 2009-12-23 Kinemed, Inc. Compositions for the treatment of fibrotic diseases or conditions
JP7164619B2 (ja) 2017-11-24 2022-11-01 ファルバリス ネザーランズ ベー．ヴェー． 新規ブラジキニンｂ２受容体アンタゴニスト
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
WO1989009230A1 (en) * 1988-03-25 1989-10-05 Administrators Of The Tulane Educational Fund Therapeutic peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
CA2106677A1 (en) * 1991-04-01 1992-10-02 John C. Cheronis Bradykinin antagonists
AU1873992A (en) * 1991-04-19 1992-11-17 Nova Technology Limited Partnership Bradykinin antagonist peptides
CA2106768C (en) * 1991-04-19 2000-09-19 Donald J. Kyle Bradykinin type peptides
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW258739B (pt) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994006453A1 (en) * 1992-09-11 1994-03-31 Stewart John M Bradykinin antagonists containing aliphatic amino acids in the 5-position
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
CA2171446C (en) * 1993-09-09 2004-11-23 Donald James Kyle Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
EP0813544B1 (en) * 1994-03-09 2004-10-27 Cortech, Inc. Bradykinin antagonist peptides incorporating n-substituted glycines

Also Published As

Publication number Publication date
MX9702292A (es) 1997-09-30
EP0797997A2 (de) 1997-10-01
EP0797997A3 (de) 2000-05-31
KR100453394B1 (ko) 2004-12-30
CZ90797A3 (en) 1997-10-15
ATE297749T1 (de) 2005-07-15
DE59712344D1 (de) 2005-07-21
HUP9700642A3 (en) 1998-03-02
ES2242973T3 (es) 2005-11-16
NO971453D0 (no) 1997-03-26
IL120521A0 (en) 1997-07-13
NO971453L (no) 1997-09-29
SK39297A3 (en) 1997-10-08
AU1651697A (en) 1997-10-02
DE19612067A1 (de) 1997-10-02
US5863901A (en) 1999-01-26
JPH1017491A (ja) 1998-01-20
SI0797997T1 (en) 2005-10-31
EP0797997B1 (de) 2005-06-15
PL319193A1 (en) 1997-09-29
KR970064622A (ko) 1997-10-13
CN1164421A (zh) 1997-11-12
HRP970171A2 (en) 1998-04-30
CA2200040A1 (en) 1997-09-27
HU9700642D0 (en) 1997-05-28
TR199700228A2 (xx) 1997-10-21
ID16413A (id) 1997-09-25
PT797997E (pt) 2005-09-30
JP4185169B2 (ja) 2008-11-26
HUP9700642A2 (hu) 1998-01-28
DK0797997T3 (da) 2005-10-17
ZA972599B (en) 1997-09-29

Similar Documents

Publication Publication Date Title
PT932398E (pt) Utilizacao do topiramento ou dos seus derivados para a producao de um medicamento para o tratamento de disturbios bipolares maniaco- depressivos
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
BR9703603A (pt) Uso de sais de estrôncio para a produção de composiç es farmaceûticas pretendidas para o tratamento de artrose
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0115162A (pt) Tratamentos antitumorais eficazes
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
EE03420B1 (et) Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
BR9814214A (pt) Composição com ácido azeláico
EP1440691A3 (en) Treatment of neurotic disorders
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
BR9701455A (pt) Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
ZA925130B (en) Pharmaceutical formulation.
SE9602262D0 (sv) New use of derivatives of cystine
MX9303074A (es) Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
WO2002019964A3 (en) Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]